LEWIS SWARTHOUT: Open Payments
NPI 1437593894 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 86 payments from 16 companies in 2025. Trend: 2023 $1,644 · 2024 $1,571 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $350 |
| Otsuka America Pharmaceutical, Inc. | 9 | $167 |
| Neurocrine BioSciences, Inc. | 6 | $160 |
| Alkermes, Inc. | 9 | $155 |
| Janssen Pharmaceuticals, Inc | 4 | $120 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| Lundbeck LLC | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, INVEGA SUSTENNA, Auvelity, FANAPT, AUSTEDO XR.
Industry payments across CO — which companies pay providers there.
